Ptc Therapeutics (PTCT) Leases: 2019-2025
Historic Leases for Ptc Therapeutics (PTCT) over the last 6 years, with Sep 2025 value amounting to $80.7 million.
- Ptc Therapeutics' Leases rose 35.68% to $80.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.7 million, marking a year-over-year increase of 35.68%. This contributed to the annual value of $56.7 million for FY2024, which is 38.32% down from last year.
- Latest data reveals that Ptc Therapeutics reported Leases of $80.7 million as of Q3 2025, which was up 43.66% from $56.2 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Leases registered a high of $141.6 million during Q2 2022, and its lowest value of $56.2 million during Q2 2025.
- Over the past 3 years, Ptc Therapeutics' median Leases value was $80.7 million (recorded in 2025), while the average stood at $76.4 million.
- Its Leases has fluctuated over the past 5 years, first soared by 173.77% in 2021, then tumbled by 40.91% in 2024.
- Quarterly analysis of 5 years shows Ptc Therapeutics' Leases stood at $77.4 million in 2021, then skyrocketed by 32.30% to $102.4 million in 2022, then decreased by 10.28% to $91.9 million in 2023, then tumbled by 38.32% to $56.7 million in 2024, then spiked by 35.68% to $80.7 million in 2025.
- Its Leases stands at $80.7 million for Q3 2025, versus $56.2 million for Q2 2025 and $57.3 million for Q1 2025.